BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37393270)

  • 1. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome.
    Xing J; Luo X; Jia K; Liu S; Chen S; Qiao G; Zhang C; Yi J
    J Ovarian Res; 2023 Jul; 16(1):128. PubMed ID: 37393270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
    Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
    J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of
    Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
    J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
    [No Abstract]   [Full Text] [Related]  

  • 4. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
    Shi N; Zhou Y; Ma H
    Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
    Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
    BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
    Yu J; Fu Y; Zeng L; Zheng Y
    Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo.
    Zheng R; Shen H; Li J; Zhao J; Lu L; Hu M; Lin Z; Ma H; Tan H; Hu M; Li J
    J Ethnopharmacol; 2023 Jan; 301():115824. PubMed ID: 36273747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
    Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
    Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome.
    Tiwari A; Modi SJ; Girme A; Hingorani L
    Medicine (Baltimore); 2023 Aug; 102(32):e34514. PubMed ID: 37565925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair.
    Li X; Ullah I; Hou C; Liu Y; Xiao K
    Medicine (Baltimore); 2023 Nov; 102(46):e36118. PubMed ID: 37986355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.
    Zhang YY; Ma JX; Zhu YT; Wang YX; Chen WQ; Sun X; Zhang W; Wang CY; Ding CF
    J Ovarian Res; 2022 Apr; 15(1):40. PubMed ID: 35379295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer.
    Liang H; Li Y; Wang F; Zhao J; Yang X; Wu D; Zhang C; Liu Y; Huang J; Su M; He Z; Liu Y; Wang J; Tang D
    Front Pharmacol; 2022; 13():862966. PubMed ID: 35774597
    [No Abstract]   [Full Text] [Related]  

  • 13. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
    Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
    J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
    Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
    Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
    Ma K; Gong LJ; Chen YX; Tian CD
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics combined with network pharmacology to explore the mechanisms of modified Guishen pill to ameliorate polycystic ovary syndrome.
    Tian J; Xu Y; Xiong Y; Zuo L; Zhou M; Cao C; Huang X; Wang J
    Comput Biol Med; 2022 Sep; 148():105790. PubMed ID: 35839542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome.
    Cai YL; Zhang F; Dou XX; Zeng HW; Wu GS; Liang YL; Xu XK; Zhao J; Ye J; Zhang WD
    J Ethnopharmacol; 2022 Sep; 295():115442. PubMed ID: 35688255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic analysis reveals that the anti-PCOS effects of Zishen Qingre Lishi Huayu recipe may involve pathways and genes related to autophagy, steroidogenesis, oxidative stress, and inflammation in granulosa cells.
    Liang R; Sheng M; Li X; Jin J; Yi Y
    J Ethnopharmacol; 2023 Oct; 314():116551. PubMed ID: 37121450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.
    Li X; Ma J; Guo L; Dong C; Zhu G; Hong W; Chen C; Wang H; Wu X
    Oxid Med Cell Longev; 2022; 2022():3145938. PubMed ID: 35528524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.